I recently argued that SpaceX is much more than a billionaire's ego trip – even if its revenue model is sometimes obscured by grandiose schemes like taking rich tourists to the moon. Some news has recently emerged on the NASA website which confirms my view that space is becoming a serious business – and which promises an exciting crossover between space travel and medical research.
The SpaceX capsule Dragon safely returned to Earth from its latest mission to the International Space Station (ISS) on Sunday, 19 March – and it came back with the results of some important medical experiments. A number of ongoing initiatives, including the Microgravity Expanded Stem Cells project and the Tissue Regeneration-Bone Defect study, are taking advantage of zero gravity conditions in space to conduct experiments in the realm of life science.
Did you miss Jim Mellon's explosive keynote talk at this year's Master Investor Show? Or would you like to hear more from the UK's smartest investor? Tonight, Jim Mellon will present at an exclusive investor evening hosted by Turner Pope Investments Ltd.
by Robert Stephens| Equities| 5 mins. to read A change in strategy can reignite a company's profit growth. Or, it can lead to large opportunity costs. In my opinion, Centrica's decision to refocus on its customer-facing supply business at the expense of its Oil & Gas operations falls into the latter category.
by Zak Mir | Trading | 1 mins. to read With the recent story of Boohoo.com (LON:BOO) it appears clear that there is little point being a High Street general retailer, paying business rates and of course the minimum wage.
by Tim Price | Economics | 8 mins. to read Back in 1998, the author Michael Lewis, then a columnist for Bloomberg, wrote as follows: "When historians of everyday life look back on 20th-century American capitalism they will be astonished by the role played by our stockbrokers".
by Nick Sudbury | Funds | 5 mins. to read One of the advantages of using investment trusts is that if you get the timing right you can benefit from the strong performance of the underlying assets and a narrowing of the discount.
Material contained within Master Investor Magazine and its website is for general information purposes only and is not intended to be relied upon by individual readers in making (or refraining from making) any specific investment decisions. Master Investor Ltd. does not accept any liability for any losses suffered by any user as a result or any such descision.
Ingen kommentarer:
Send en kommentar